NASDAQ
Candel Therapeutics, Inc. (CADL) has a current ratio of 13.31x as of Monday, May 25, 2026. This represents a 56.49% increase compared to its 12-month average of 8.50x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.